Published January 1, 2021
| Version v1
Journal article
Open
White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers
Creators
- van Doorn, Linda J. C. van Waalwijk
- Ghafoorian, Mohsen1
- van Leijsen, Esther M. C.2
- Claassen, Jurgen A. H. R.3
- Arighi, Andrea4
- Bozzali, Marco
- Cannas, Jorge5
- Cavedo, Enrica
- Eusebi, Paolo6
- Farotti, Lucia6
- Fenoglio, Chiara7
- Fortea, Juan
- Frisoni, Giovanni B.
- Galimberti, Daniela
- Greco, Viviana
- Herukka, Sanna-Kaisa
- Liu, Yawu
- Lleo, Alberto
- de Mendonca, Alexandre5
- Nobili, Flavio M.
- Nobili, Flavio M.
- 1. Radboud Univ Nijmegen, Dept Radiol & Nucl Med, Med Ctr, Nijmegen, Netherlands
- 2. Radboud Univ Nijmegen, Radboud Alzheimer Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol,Med Ctr, Nijmegen, Netherlands
- 3. Radboud Univ Nijmegen, Radboud Alzheimer Ctr, Donders Inst Brain Cognit & Behav, Dept Geriatr,Med Ctr, Nijmegen, Netherlands
- 4. Fdn IRCCS Ca Granda, Osped Policlin, Milan, Italy
- 5. Univ Lisbon, Fac Med, Lisbon, Portugal
- 6. Univ Perugia, Ctr Memory Disturbances, Sect Neurol, Perugia, Italy
- 7. Univ Milan, Dino Ferrari Ctr, Milan, Italy
Description
Background: The cerebrospinal fluid (CSF) biomarkers amyloid-beta 1-42 (A beta(42)), total and phosphorylated tau (t-tau, p-tau) are increasingly used to assist in the clinical diagnosis of Alzheimer's disease (AD). However, CSF biomarker levels can be affected by confounding factors.
Files
bib-d6d11e24-e58f-4ec4-a8ce-635e38464d1c.txt
Files
(428 Bytes)
| Name | Size | Download all |
|---|---|---|
|
md5:be1503ad3ed07ea8a8796b646828816f
|
428 Bytes | Preview Download |